Medication Prescribing and Adherence Patterns Among Prison Inmates With Diabetes Mellitus

Jacques Baillargeon, Adrianne D. Linton, Sandra A. Black, Stephanie Zepeda, James J. Grady

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Diabetes is one of the most common and costly medical conditions among prison inmates. Scarce information, however, currently exists about the management of this condition in the correctional setting. The purpose of this study was to describe antidiabetic agent prescribing patterns and adherence among diabetic prison inmates. The study population consisted of 4,061 Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between December 1, 1998, and March 31, 1999, and who were diagnosed with either Type 1 or Type 2 diabetes mellitus. Approximately one-third (33%) of the study subjects were prescribed insulin only, 38% were prescribed oral hypoglycemic agents (OHA) only, 13% were prescribed both insulin and OHA, and 13% received no medication. The median adherence rates with drug therapy were 61% for insulin only, and 66% for OHA only. For combination therapy, the median adherence rate was 56% for insulin and 66% for OHA. The authors noted that the rate of insulin-only therapy and OHA and insulin combination therapy among TDCJ inmates was higher than that reported among previous studies of nonincarcerated samples. Alternatively, it was reported that the rate of OHA-only therapy and no therapy was lower among inmates than among their free-world counterparts. It is likely, however, that these differences were driven, in large part, by the underlying differences in the demographic composition of the study samples. It will be important for investigators to examine whether future studies of inmate populations exhibit similar pharmacotherapy and compliance rates, and moreover to assess whether such rates differ substantially from nonincarcerated samples, even after adjusting for sociodemographic factors.

Original languageEnglish (US)
Pages (from-to)37-53
Number of pages17
JournalJournal of Correctional Health Care
Volume8
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Medication Adherence
Prisons
Hypoglycemic Agents
Diabetes Mellitus
Insulin
Criminal Law
Therapeutics
Drug Therapy
Type 2 Diabetes Mellitus
Population
Research Personnel
Demography

ASJC Scopus subject areas

  • Community and Home Care
  • Public Health, Environmental and Occupational Health

Cite this

Medication Prescribing and Adherence Patterns Among Prison Inmates With Diabetes Mellitus. / Baillargeon, Jacques; Linton, Adrianne D.; Black, Sandra A.; Zepeda, Stephanie; Grady, James J.

In: Journal of Correctional Health Care, Vol. 8, No. 1, 2001, p. 37-53.

Research output: Contribution to journalArticle

Baillargeon, Jacques ; Linton, Adrianne D. ; Black, Sandra A. ; Zepeda, Stephanie ; Grady, James J. / Medication Prescribing and Adherence Patterns Among Prison Inmates With Diabetes Mellitus. In: Journal of Correctional Health Care. 2001 ; Vol. 8, No. 1. pp. 37-53.
@article{aaead729c52345eb93f88cfe776d5cec,
title = "Medication Prescribing and Adherence Patterns Among Prison Inmates With Diabetes Mellitus",
abstract = "Diabetes is one of the most common and costly medical conditions among prison inmates. Scarce information, however, currently exists about the management of this condition in the correctional setting. The purpose of this study was to describe antidiabetic agent prescribing patterns and adherence among diabetic prison inmates. The study population consisted of 4,061 Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between December 1, 1998, and March 31, 1999, and who were diagnosed with either Type 1 or Type 2 diabetes mellitus. Approximately one-third (33{\%}) of the study subjects were prescribed insulin only, 38{\%} were prescribed oral hypoglycemic agents (OHA) only, 13{\%} were prescribed both insulin and OHA, and 13{\%} received no medication. The median adherence rates with drug therapy were 61{\%} for insulin only, and 66{\%} for OHA only. For combination therapy, the median adherence rate was 56{\%} for insulin and 66{\%} for OHA. The authors noted that the rate of insulin-only therapy and OHA and insulin combination therapy among TDCJ inmates was higher than that reported among previous studies of nonincarcerated samples. Alternatively, it was reported that the rate of OHA-only therapy and no therapy was lower among inmates than among their free-world counterparts. It is likely, however, that these differences were driven, in large part, by the underlying differences in the demographic composition of the study samples. It will be important for investigators to examine whether future studies of inmate populations exhibit similar pharmacotherapy and compliance rates, and moreover to assess whether such rates differ substantially from nonincarcerated samples, even after adjusting for sociodemographic factors.",
author = "Jacques Baillargeon and Linton, {Adrianne D.} and Black, {Sandra A.} and Stephanie Zepeda and Grady, {James J.}",
year = "2001",
doi = "10.1177/107834580100800103",
language = "English (US)",
volume = "8",
pages = "37--53",
journal = "Journal of Correctional Health Care",
issn = "1078-3458",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Medication Prescribing and Adherence Patterns Among Prison Inmates With Diabetes Mellitus

AU - Baillargeon, Jacques

AU - Linton, Adrianne D.

AU - Black, Sandra A.

AU - Zepeda, Stephanie

AU - Grady, James J.

PY - 2001

Y1 - 2001

N2 - Diabetes is one of the most common and costly medical conditions among prison inmates. Scarce information, however, currently exists about the management of this condition in the correctional setting. The purpose of this study was to describe antidiabetic agent prescribing patterns and adherence among diabetic prison inmates. The study population consisted of 4,061 Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between December 1, 1998, and March 31, 1999, and who were diagnosed with either Type 1 or Type 2 diabetes mellitus. Approximately one-third (33%) of the study subjects were prescribed insulin only, 38% were prescribed oral hypoglycemic agents (OHA) only, 13% were prescribed both insulin and OHA, and 13% received no medication. The median adherence rates with drug therapy were 61% for insulin only, and 66% for OHA only. For combination therapy, the median adherence rate was 56% for insulin and 66% for OHA. The authors noted that the rate of insulin-only therapy and OHA and insulin combination therapy among TDCJ inmates was higher than that reported among previous studies of nonincarcerated samples. Alternatively, it was reported that the rate of OHA-only therapy and no therapy was lower among inmates than among their free-world counterparts. It is likely, however, that these differences were driven, in large part, by the underlying differences in the demographic composition of the study samples. It will be important for investigators to examine whether future studies of inmate populations exhibit similar pharmacotherapy and compliance rates, and moreover to assess whether such rates differ substantially from nonincarcerated samples, even after adjusting for sociodemographic factors.

AB - Diabetes is one of the most common and costly medical conditions among prison inmates. Scarce information, however, currently exists about the management of this condition in the correctional setting. The purpose of this study was to describe antidiabetic agent prescribing patterns and adherence among diabetic prison inmates. The study population consisted of 4,061 Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between December 1, 1998, and March 31, 1999, and who were diagnosed with either Type 1 or Type 2 diabetes mellitus. Approximately one-third (33%) of the study subjects were prescribed insulin only, 38% were prescribed oral hypoglycemic agents (OHA) only, 13% were prescribed both insulin and OHA, and 13% received no medication. The median adherence rates with drug therapy were 61% for insulin only, and 66% for OHA only. For combination therapy, the median adherence rate was 56% for insulin and 66% for OHA. The authors noted that the rate of insulin-only therapy and OHA and insulin combination therapy among TDCJ inmates was higher than that reported among previous studies of nonincarcerated samples. Alternatively, it was reported that the rate of OHA-only therapy and no therapy was lower among inmates than among their free-world counterparts. It is likely, however, that these differences were driven, in large part, by the underlying differences in the demographic composition of the study samples. It will be important for investigators to examine whether future studies of inmate populations exhibit similar pharmacotherapy and compliance rates, and moreover to assess whether such rates differ substantially from nonincarcerated samples, even after adjusting for sociodemographic factors.

UR - http://www.scopus.com/inward/record.url?scp=84941963471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941963471&partnerID=8YFLogxK

U2 - 10.1177/107834580100800103

DO - 10.1177/107834580100800103

M3 - Article

VL - 8

SP - 37

EP - 53

JO - Journal of Correctional Health Care

JF - Journal of Correctional Health Care

SN - 1078-3458

IS - 1

ER -